Immunological and Clinical Impact of Manipulated and Unmanipulated DLI after Allogeneic Stem Cell Transplantation of AML Patients
Allogeneic stem cell transplantation (allo-SCT) is the preferred curative treatment for several hematological malignancies. The efficacy of allo-SCT depends on the graft-versus-leukemia (GvL) effect. However, the prognosis of patients with relapsed acute myeloid leukemia (AML) following allo-SCT is...
Main Authors: | Jochen Greiner, Marlies Götz, Donald Bunjes, Susanne Hofmann, Verena Wais |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-12-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/1/39 |
Similar Items
-
Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner
by: Simona Jahnke, et al.
Published: (2019-07-01) -
Effective Immunosurveillance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
by: Kunadt D, et al.
Published: (2021-09-01) -
The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
by: Christos Demosthenous, et al.
Published: (2021-05-01) -
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis
by: Narendranath Epperla, et al.
Published: (2019-01-01) -
Reduced-intensity conditioning allogeneic stem cell transplantation in malignant lymphoma: current status
by: Le Zhang, et al.
Published: (2013-03-01)